Alison C. West

7.8k total citations · 1 hit paper
38 papers, 2.3k citations indexed

About

Alison C. West is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Alison C. West has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Immunology and 12 papers in Oncology. Recurrent topics in Alison C. West's work include Inflammasome and immune disorders (8 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Protein Degradation and Inhibitors (6 papers). Alison C. West is often cited by papers focused on Inflammasome and immune disorders (8 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Protein Degradation and Inhibitors (6 papers). Alison C. West collaborates with scholars based in Australia, United States and Japan. Alison C. West's co-authors include Ricky W. Johnstone, Mark J. Smyth, Brendan J. Jenkins, Nicole M. Haynes, Ailsa J. Christiansen, Jake Shortt, Jesse J. Balic, Stephen R. Mattarollo, Leslie L. Sharp and Inge Verbrugge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Alison C. West

36 papers receiving 2.3k citations

Hit Papers

New and emerging HDAC inhibitors for cancer treatment 2014 2026 2018 2022 2014 250 500 750 1000

Peers

Alison C. West
Sheng-Bin Peng United States
Emily Chu United States
Jennifer L. Guerriero United States
Venkatesh Krishnan United States
Sachi Horibata United States
Anna E. Vilgelm United States
Alison C. West
Citations per year, relative to Alison C. West Alison C. West (= 1×) peers Stephanie Grabow

Countries citing papers authored by Alison C. West

Since Specialization
Citations

This map shows the geographic impact of Alison C. West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison C. West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison C. West more than expected).

Fields of papers citing papers by Alison C. West

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison C. West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison C. West. The network helps show where Alison C. West may publish in the future.

Co-authorship network of co-authors of Alison C. West

This figure shows the co-authorship network connecting the top 25 collaborators of Alison C. West. A scholar is included among the top collaborators of Alison C. West based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison C. West. Alison C. West is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deswaerte, Virginie, Alison C. West, Beena Kumar, et al.. (2023). The cytosolic DNA sensor AIM2 promotes Helicobacter‐induced gastric pathology via the inflammasome. Immunology and Cell Biology. 101(5). 444–457. 9 indexed citations
2.
3.
Harpur, Christopher M., et al.. (2023). Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection. Clinical & Translational Immunology. 12(3). e1443–e1443. 5 indexed citations
4.
West, Alison C., Christopher M. Harpur, Maggie Lam, et al.. (2023). Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza. The Journal of Infectious Diseases. 230(2). e384–e394. 2 indexed citations
5.
Deswaerte, Virginie, et al.. (2022). Inflammasome-Associated Gastric Tumorigenesis Is Independent of the NLRP3 Pattern Recognition Receptor. Frontiers in Oncology. 12. 830350–830350. 7 indexed citations
6.
Tang, Ke, Louise McLeod, Alison C. West, et al.. (2022). Toll-like Receptor 9 Promotes Initiation of Gastric Tumorigenesis by Augmenting Inflammation and Cellular Proliferation. Cellular and Molecular Gastroenterology and Hepatology. 14(3). 567–586. 13 indexed citations
7.
Alhayyani, Sultan, Louise McLeod, Alison C. West, et al.. (2021). Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer. Oncogene. 41(6). 809–823. 9 indexed citations
8.
Balic, Jesse J., Mohamed I. Saad, Louise McLeod, et al.. (2020). Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric Disease. American Journal Of Pathology. 190(6). 1256–1270. 20 indexed citations
9.
Balic, Jesse J., Daniel J. Garama, Mohamed I. Saad, et al.. (2019). Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity. Cancer Research. 79(20). 5272–5287. 28 indexed citations
10.
Deswaerte, Virginie, Paul M. Nguyen, Alison C. West, et al.. (2017). Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism. Cancer Research. 78(5). 1293–1307. 66 indexed citations
11.
West, Alison C., Ke Tang, Hazel Tye, et al.. (2017). Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer. Oncogene. 36(36). 5134–5144. 53 indexed citations
12.
West, Alison C., Benjamin P. Martin, Daniel M. Andrews, et al.. (2016). The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock. Oncogenesis. 5(4). e216–e216. 24 indexed citations
13.
West, Alison C. & Brendan J. Jenkins. (2015). Inflammatory and Non-Inflammatory Roles for Toll-Like Receptors in Gastrointestinal Cancer. Current Pharmaceutical Design. 21(21). 2968–2977. 20 indexed citations
14.
Taberlay, Phillippa C., Arabella Young, Alison C. West, et al.. (2015). The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1. Journal of Cellular Biochemistry. 117(1). 49–58. 9 indexed citations
15.
West, Alison C., Mark J. Smyth, & Ricky W. Johnstone. (2014). The anticancer effects of HDAC inhibitors require the immune system. OncoImmunology. 3(1). e27414–e27414. 68 indexed citations
16.
West, Alison C., Stephen R. Mattarollo, Jake Shortt, et al.. (2013). An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors. Cancer Research. 73(24). 7265–7276. 117 indexed citations
17.
John, Liza B., Jacqueline K. Flynn, Alison C. West, et al.. (2012). Oncolytic Virus and Anti–4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer. Cancer Research. 72(7). 1651–1660. 92 indexed citations
18.
Verbrugge, Inge, Jim Hagekyriakou, Leslie L. Sharp, et al.. (2012). Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies. Cancer Research. 72(13). 3163–3174. 222 indexed citations
19.
James, Sally, et al.. (2010). Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Leukemia Research. 34(9). 1203–1213. 17 indexed citations
20.
Gilchrist, Alison, et al.. (1999). SRB 6 : involving the community. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026